38 related articles for article (PubMed ID: 15006258)
21. [Progesterone and breast cancer].
Mansueto G; Mistretta V; Angeletti F; Trento LK; Angelozzi D; Bracaglia M; Pagliarella MR; Di Muccio L
Recenti Prog Med; 2006; 97(7-8):376-80. PubMed ID: 16913172
[TBL] [Abstract][Full Text] [Related]
22. The Million Women Study and breast cancer.
Speroff L
Maturitas; 2003 Sep; 46(1):1-6. PubMed ID: 12963165
[No Abstract] [Full Text] [Related]
23. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
24. Hormone therapy and breast cancer risk.
Foidart JM; Desreux J; Pintiaux A; Gompel A
Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
[TBL] [Abstract][Full Text] [Related]
25. [Effects of estrogen and selective estrogen receptor modulators on osteoporosis].
Urano T
Clin Calcium; 2005 Apr; 15(4):591-5. PubMed ID: 15802770
[TBL] [Abstract][Full Text] [Related]
26. Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
Neves-E-Castro M
Clin Obstet Gynecol; 2008 Sep; 51(3):607-17. PubMed ID: 18677154
[TBL] [Abstract][Full Text] [Related]
27. [Sexual dysfunction in the menopause. Incidence, pharmacological treatment and side effects].
Gregersen N; Hilmand CB; Jensen PT; Giraldi AG
Ugeskr Laeger; 2006 Feb; 168(6):559-63. PubMed ID: 16476214
[TBL] [Abstract][Full Text] [Related]
28. Systemic lupus erythematosus and hormone replacement therapy.
Gompel A; Piette JC
Menopause Int; 2007 Jun; 13(2):65-70. PubMed ID: 17540136
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer risk in the WHI study: the problem of obesity.
Kuhl H
Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
[TBL] [Abstract][Full Text] [Related]
30. Postmenopausal hormone therapy and the risk of breast cancer. A clinician's view.
Speroff L
Maturitas; 2004 Sep; 49(1):51-7. PubMed ID: 15351096
[TBL] [Abstract][Full Text] [Related]
31. Estrogen use and cancer incidence: a review.
Lupulescu A
Cancer Invest; 1995; 13(3):287-95. PubMed ID: 7743382
[No Abstract] [Full Text] [Related]
32. What is tibolone--and is it a SPEAR?
Purdie DW
Climacteric; 2002 Sep; 5(3):236-9. PubMed ID: 12419081
[No Abstract] [Full Text] [Related]
33. Breast cancer: progress at last?
Skegg DC
Lancet; 1995 Dec 23-30; 346 Suppl():s15. PubMed ID: 9454032
[No Abstract] [Full Text] [Related]
34. Some comments on the Million Women Study.
Neves-E-Castro M
Climacteric; 2003 Dec; 6(4):357. PubMed ID: 15006258
[No Abstract] [Full Text] [Related]
35. Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.
Biglia N; Maffei S; Lello S; Nappi RE
Gynecol Endocrinol; 2010 Nov; 26(11):804-14. PubMed ID: 20586550
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer: the role of hormone therapy.
Creasman WT
Semin Reprod Med; 2005 May; 23(2):167-71. PubMed ID: 15852202
[TBL] [Abstract][Full Text] [Related]
37. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
Speroff L
Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
[TBL] [Abstract][Full Text] [Related]
38. Effects of hormone treatment on hemostasis variables.
Kluft C
Climacteric; 2007 Oct; 10 Suppl 2():32-7. PubMed ID: 17882670
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
